Physician profile
Kellie E Wheeler
NPI 1629590187
$1,335.71
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $325 · 2023: $252 · 2024: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $534.55 | 2022-2024 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $234.58 | 2022-2024 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $201.04 | 2022-2024 | Stelara, Simponi, Simponi Aria |
| Celgene Corporation | $141.27 | 2023-2024 | Zeposia |
| Abbvie INC. | $94.96 | 2023-2024 | |
| Genzyme Corporation | $63.58 | 2022 | |
| Qol Medical, LLC | $25.49 | 2023 | Sucraid |
| Phathom Pharmaceuticals, INC. | $21.05 | 2024 | Voquezna |
| Ardelyx, INC. | $19.19 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.